Insider · CIK 0001738048
Venrock Healthcare Capital Partners III, L.P.
Files at ORKA (Oruka Therapeutics, Inc.), KALV (KalVista Pharmaceuticals, Inc.). First filing Feb 3, 2025, latest Apr 11, 2025.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
ORKA: Oruka Therapeutics, Inc.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 20Weak | KALVbuy KalVista Pharmaceuticals, Inc. | $236k 25,000 shares | +0% | - | |
| 32Weak | ORKAbuy Oruka Therapeutics, Inc. | $1.4M 122,882 shares | +3% | - | |
| 37Weak | KALVbuy KalVista Pharmaceuticals, Inc. | $1.5M 161,700 shares | +3% | - | |
| 37Weak | KALVbuy KalVista Pharmaceuticals, Inc. | $967k 104,489 shares | +2% | - | |
| 27Weak | KALVbuy KalVista Pharmaceuticals, Inc. | $622k 70,023 shares | +1% | - |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Apr 9, 2025 | KALV KalVista Pharmaceuticals, Inc. | POpen-market purchase Common Stockindirect: By Funds | +25,000 | $9.42 | $236k | 5,303,985 | Apr 11, 2025 |
| Feb 10, 2025 | ORKA Oruka Therapeutics, Inc. | POpen-market purchase Common Stockindirect: By Funds | +574 | $10.90 | $6,257 | 4,026,120 | Feb 27, 2025 |
| Feb 11, 2025 | ORKA Oruka Therapeutics, Inc. | POpen-market purchase Common Stockindirect: By Funds | +9,593 | $10.95 | $105k | 4,035,713 | Feb 27, 2025 |
| Feb 12, 2025 | ORKA Oruka Therapeutics, Inc. | POpen-market purchase Common Stockindirect: By Funds | +8,971 | $11.86 | $106k | 4,044,684 | Feb 27, 2025 |
| Feb 13, 2025 | ORKA Oruka Therapeutics, Inc. | POpen-market purchase Common Stockindirect: By Funds | +14,950 | $11.63 | $174k | 4,059,634 | Feb 27, 2025 |
| Feb 14, 2025 | ORKA Oruka Therapeutics, Inc. | POpen-market purchase Common Stockindirect: By Funds | +88,794 | $11.44 | $1.0M | 4,148,428 | Feb 27, 2025 |
| Feb 12, 2025 | KALV KalVista Pharmaceuticals, Inc. | POpen-market purchase Common Stockindirect: By Funds | +100,000 | $9.23 | $923k | 5,217,285 | Feb 14, 2025 |
| Feb 13, 2025 | KALV KalVista Pharmaceuticals, Inc. | POpen-market purchase Common Stockindirect: By Funds | +61,700 | $9.33 | $576k | 5,278,985 | Feb 14, 2025 |
| Feb 7, 2025 | KALV KalVista Pharmaceuticals, Inc. | POpen-market purchase Common Stockindirect: By Funds | +73,649 | $9.29 | $684k | 5,086,445 | Feb 11, 2025 |
| Feb 10, 2025 | KALV KalVista Pharmaceuticals, Inc. | POpen-market purchase Common Stockindirect: By Funds | +4,137 | $9.14 | $38k | 5,090,582 | Feb 11, 2025 |
| Feb 11, 2025 | KALV KalVista Pharmaceuticals, Inc. | POpen-market purchase Common Stockindirect: By Funds | +26,703 | $9.18 | $245k | 5,117,285 | Feb 11, 2025 |
| Jan 30, 2025 | KALV KalVista Pharmaceuticals, Inc. | POpen-market purchase Common Stockindirect: By Funds | +43,707 | $8.76 | $383k | 4,986,480 | Feb 3, 2025 |
| Jan 31, 2025 | KALV KalVista Pharmaceuticals, Inc. | POpen-market purchase Common Stockindirect: By Funds | +11,754 | $8.89 | $104k | 4,998,234 | Feb 3, 2025 |
| Feb 3, 2025 | KALV KalVista Pharmaceuticals, Inc. | POpen-market purchase Common Stockindirect: By Funds | +14,562 | $9.22 | $134k | 5,012,796 | Feb 3, 2025 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.